Earnings History Data for Galmed Pharmaceuticals Ltd. (GLMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
17-05-2022	PM	7:00 AM ET (May 17)	GLMD	Galmed Pharmaceuticals	15.00	-0.24	-0.33	0.00	Galmed GAAP EPS of -$0.24 beats by $0.08 [5/17/2022 8:50 AM]	0.58	0.01 (0.97%)	0.64	0.07 (12.29%)	0.55 - 4.08	88,965	210,000	7,188
Galmed GAAP EPS of -$0.24 beats by $0.08 [5/17/2022 8:50 AM] Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results [May-17-22 08:00AM] Galmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effects [May-17-22 07:30AM]
02-05-2022	PM	7:30 AM ET (May 2)	GLMD	Galmed Pharmaceuticals	38.00	-0.30	-0.30	0.00	Galmed GAAP EPS of -$0.30 in-line [5/2/2022 7:06 AM]	1.24	-0.42 (-25.30%)	1.53	-0.13 (-7.83%)	1.19 - 4.08	176,421	50,000	2,559
Galmed GAAP EPS of -$0.30 in-line [5/2/2022 7:06 AM] Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2021 Financial Results [May-02-22 07:00AM]
08-11-2021	PM	7:00 AM ET (Nov 8)	GLMD	Galmed Pharmaceuticals	71.00	-0.31	-0.40	0.00	Galmed EPS beats by $0.67 [11/8/2021 7:35 AM]	2.98	0.18 (6.43%)	2.95	0.15 (5.36%)	2.15 - 6.25	333,783	200,000	249,168
Galmed EPS beats by $0.67 [11/8/2021 7:35 AM] Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of ARMOR Study and Reports Third Quarter 2021 Financial Results [Nov-08-21 07:30AM] Galmed Announces New Positive Data from Ongoing ARMOR Study Open Label Part Showing Clinically Significant Effect on Fibrosis Improvement [Nov-08-21 07:00AM]
05-08-2021	PM	7:50 AM ET (Aug 5)	GLMD	Galmed Pharmaceuticals Ltd.	59.12	-0.33	-0.41	-0.26	Galmed EPS beats by $0.05 [8/5/2021 7:11 AM]	2.87	0.13 (4.74%)	2.88	0.14 (5.11%)	2.15 - 6.25	161,820	900,000	928
Galmed EPS beats by $0.05 [8/5/2021 7:11 AM] Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results [Aug-05-21 07:00AM]
13-05-2021	PM	7:00 AM ET (May 13)	GLMD	Galmed Pharmaceuticals Ltd.	50.88	-0.38	-0.44	-0.29	Galmed EPS beats by $0.01 [5/13/2021 7:53 AM]	2.24	-0.20 (-8.20%)	2.59	0.15 (6.15%)	2.15 - 6.29	274,718	440,000	1,016
Galmed EPS beats by $0.01 [5/13/2021 7:53 AM] Galmed Pharmaceuticals Ltd. to Host Earnings Call [May-13-21 06:30AM] Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial Results [May-13-21 07:50AM]
18-03-2021	PM	7:00 AM ET (Mar 18)	GLMD	Galmed Pharmaceuticals Ltd.	76.01	-0.48	-0.40	-0.39	Galmed EPS misses by $0.11 [3/18/2021 7:04 AM]	3.42	-0.06 (-1.86%)	3.48	-0.01 (-0.29%)	2.96 - 6.29	291,533	410,000	9,288
Galmed EPS misses by $0.11 [3/18/2021 7:04 AM] Galmed Pharmaceuticals Ltd. to Host Earnings Call [Mar-18-21 06:30AM] Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results [Mar-18-21 07:00AM]
12-11-2020	PM	7:00 AM ET (Nov 12)	GLMD	Galmed Pharmaceuticals Ltd.	66.08	-0.32	-0.32	-0.21	Galmed EPS misses by $0.02 [11/12/2020 7:07 AM]	3.15	-0.21 (-6.25%)	3.36	0.0 (0.00%)	2.96 - 7.38	69,499	76,060	159

06-08-2020	PM	7:00 AM ET (Aug 6)	GLMD	Galmed Pharmaceuticals Ltd.	105.14	-0.26	-0.31	-0.20	Galmed EPS beats by $0.06 [8/6/2020 7:03 AM]	4.61	-0.36 (-7.28%)	5.25	0.28 (5.63%)	3.02 - 7.38	152,882	76,104	2,105

14-05-2020	PM	7:00 AM ET (May 14)	GLMD	Galmed Pharmaceuticals Ltd.	94.77	-0.29	-0.37	-0.17	Galmed EPS beats by $0.08 [5/14/2020 7:03 AM]	5.08	0.11 (2.21%)	0.0	0.0 (0.00%)	3.02 - 7.70	119,103	51,334	0